---
figid: PMC5746412__oncotarget-08-110656-g005
figlink: /pmc/articles/PMC5746412/figure/F5/
number: F5
caption: (A) Shikonin inhibit TPA-induced neoplastic cell transformation and PKM2
  to suppress aerobic glycolysis. (B) Selumetinib as an MEK's inhibitor decreases
  the expression of PKM2 and the production of lactic acid to suppress tumor cell
  proliferation. (C) TRIM35 interacts with the coiled-coil domain of PKM2 to alleviate
  the tumor cell proliferation. (D) FFJ-5 and FFJ-3 down-regulate PKM2 to inhibit
  cancer cell growth. (E) OA alternatively splices PKM transcriptional initial mRNA
  and AIC-47 disrupts Bcr-abl/mTOR/hnRNP signaling pathway to produce more PKM1 and
  abolish Warburg effect. (F) shRNA is used to knockdown PKM2 gene with PKM1 substitution
  for suppressing Warburg effect. (G) siRNAs is used to silence PKM2 gene for the
  inhibition of tumor cells.
pmcid: PMC5746412
papertitle: PKM2 in carcinogenesis and oncotherapy.
reftext: Xia He, et al. Oncotarget. 2017 Dec 15;8(66):110656-110670.
pmc_ranked_result_index: '36305'
pathway_score: 0.9182138
filename: oncotarget-08-110656-g005.jpg
figtitle: PKM2 in carcinogenesis and oncotherapy
year: '2017'
organisms: Homo sapiens
ndex: 29c4fb47-df0f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5746412__oncotarget-08-110656-g005.html
  '@type': Dataset
  description: (A) Shikonin inhibit TPA-induced neoplastic cell transformation and
    PKM2 to suppress aerobic glycolysis. (B) Selumetinib as an MEK's inhibitor decreases
    the expression of PKM2 and the production of lactic acid to suppress tumor cell
    proliferation. (C) TRIM35 interacts with the coiled-coil domain of PKM2 to alleviate
    the tumor cell proliferation. (D) FFJ-5 and FFJ-3 down-regulate PKM2 to inhibit
    cancer cell growth. (E) OA alternatively splices PKM transcriptional initial mRNA
    and AIC-47 disrupts Bcr-abl/mTOR/hnRNP signaling pathway to produce more PKM1
    and abolish Warburg effect. (F) shRNA is used to knockdown PKM2 gene with PKM1
    substitution for suppressing Warburg effect. (G) siRNAs is used to silence PKM2
    gene for the inhibition of tumor cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - PIK3R5
  - AKT3
  - AKT2
  - PIK3R6
  - PARP16
  - PARP10
  - PIK3R3
  - PARP14
  - PARP9
  - MAP2K1
  - MAP2K2
  - TNKS2
  - MAPK1
  - PKM
  - PARP8
  - CASP9
  - TIPARP
  - MTOR
  - TRIM35
  - MAPK3
  - PIK3R4
  - PIK3CA
  - CASP10
  - CASP8
  - PARP15
  - PIK3CG
  - CASP12
  - CASP14
  - PARP12
  - TNKS
  - PARP6
  - PARP11
  - PIK3CB
  - PIK3CD
  - PARP2
  - PARP3
  - CASP6
  - PARP1
  - EGFR
  - CASP2
  - CASP4
  - CASP1
  - CASP5
  - PARP4
  - MYC
  - CASP7
  - CASP3
  - Selumetinib
  - Oleanolic acid
  - Cancer
genes:
- word: P13K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P13K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P13K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKM
  symbol: PKM
  source: hgnc_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: ber-abl/mTOR/hnRNP
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TRIM35
  symbol: TRIM35
  source: hgnc_symbol
  hgnc_symbol: TRIM35
  entrez: '23087'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: EGFR/Akt/PKM2
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: C-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
chemicals:
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Oleanolic acid
  source: MESH
  identifier: D009828
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5746412__F5
redirect_from: /figures/PMC5746412__F5
figtype: Figure
---
